Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 2747-2751

  Van Mierlo, Geertje J D ^a   Scherer, Hans U ^a   Hameetman, Marjolijn ^a   Morgan, Mary E ^a   Flierman, Roelof ^a   Huizinga, Tom W J ^a   Toes, René E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; ACUTE PHASE PROTEIN; AUTACOID; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CD4+ CD25+ T LYMPHOCYTE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SECRETION; TRANSPLANTATION;

ACUTE-PHASE PROTEINS; ANIMALS; CELLS, CULTURED; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42949162462     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.2747     Document Type: Article

References (21)

1. Belkaid, Y., and B. T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6: 353-360.
2. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
3. + regulatory T cells. Immunol. Rev. 212: 60-73.
4. Waldmann, H., L. Graca, S. Cobbold, E. Adams, M. Tone, and Y. Tone. 2004. Regulatory T cells and organ transplantation. Semin. Immunol. 16: 119-126.
5. + regulatory T cell function. Eur. J. Immunol. 34: 2996-3005.
6. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
7. + regulatory T cells. Arthritis Rheum. 52: 2212-2221.
8. Gauldie, J., C. Richards, D. Harnish, P. Lansdorp, and H. Baumann. 1987. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84: 7251-7255.
9. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180: 1243-1250.
10. Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340: 448-454.
11. + T cells. Eur. J. Immunol. 37: 129-138.
12. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99-105.
13. Amiot, F., C. Fitting, K. J. Tracey, J. M. Cavaillon, and F. Dautry. 1997. Lipopolysaccharide-induced cytokine cascade and lethality in LTα/TNFα-deficient mice. Mol. Med. 3: 864-875.
14. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94: 8093-8098.
15. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
16. Baecher-Allan, C., E. Wolf, and D. A. Hafler. 2006. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176: 4622-4631.
17. hi T-regulatory cells. Blood 108: 253-261.
18. + T regulatory cells. J. Immunol. 179: 154-161.
19. + cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48: 1452-1460.
20. Holmdahl, R., K. Rubin, L. Klareskog, E. Larsson, and H. Wigzell. 1986. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum. 29: 400-410.
21. Holmdahl, R., L. Jansson, A. Larsson, and R. Jonsson. 1990. Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J. Immunol. 31: 147-157.